InfraReDx Nabs $24.1M

Burlington, MA-based medical device developer InfraReDx announced today that it had raised $24.1 million in an equity offering it sold to existing investors. The money will go to ongoing and new clinical trials exploring additional applications of its LipiScan IVUS coronary imaging system, which combines near infrared light and a type of intravascular ultrasound to provide detailed images of a type of fatty plaque in the arteries. Last October InfraReDx raised $21 million to launch the system in the U.S. shortly after it had gained FDA clearance.

Trending on Xconomy